KAZN

KAZN (kazrin) is a multifunctional adaptor protein that organizes the cytoskeleton and cell junctions of epithelia and, through distinct isoforms, contributes to endosomal trafficking (PMID:15337775, PMID:21062899, PMID:37096882). It was identified as a periplakin-interacting protein that colocalizes with periplakin and desmoplakin at desmosomes and the interdesmosomal plasma membrane and is incorporated into the keratinocyte cornified envelope, with periplakin binding mediated by its N-terminal region (PMID:15337775). In keratinocytes, kazrin controls cell shape, intercellular junction assembly, and terminal differentiation by reducing filamentous actin and reorganizing keratin filaments, acting in part through decreased RhoA activity (PMID:18840647); this cell-shape regulatory activity maps to its N-terminal coiled-coil domain (PMID:22513779). Kazrin directly binds ARVCF-catenin and stabilizes it, forms a ternary complex with ARVCF-catenin and β2-spectrin, and binds p190B RhoGAP and select p120-catenin subfamily members (δ-catenin, p0071) to maintain epithelial integrity, RhoA control, and cadherin function during Xenopus ectodermal and craniofacial/neural crest development (PMID:21062899, PMID:22028074). A distinct kazrin C isoform functions as a dynein/dynactin adaptor: its N-terminus directly binds the dynactin complex and dynein light intermediate chain 1 while its C-terminal intrinsically disordered region engages early endosome components, promoting retrograde transport of early endosomes toward recycling endosomes (PMID:37096882).

1. 2004 High

   Established kazrin's existence and first molecular anchor by showing it binds periplakin and localizes to desmosomes, the interdesmosomal membrane, and the cornified envelope, placing it in the keratinocyte junctional/cornification machinery.

   Evidence Co-IP with a defined N-terminal periplakin fragment, immunofluorescence colocalization, and cornified envelope incorporation assay in cultured keratinocytes

   PMID:15337775

   Open questions at the time

   • Functional consequence of the kazrin–periplakin interaction not tested
   • Domain of kazrin mediating binding not mapped here
2. 2005 Medium

   Documented dynamic, cell-cycle- and development-dependent relocalization of kazrin among the spindle, cytokinetic ring, nuclear matrix, and cell-cell junctions, hinting at roles beyond epidermis but without functional perturbation.

   Evidence RT-PCR, Western blot, and confocal immunofluorescence across mouse eggs and early embryos

   PMID:16086310

   Open questions at the time

   • Purely descriptive—no loss-of-function test
   • Molecular partners at each location unidentified
3. 2008 High

   Defined kazrin as a regulator of keratinocyte cytoskeleton and differentiation, linking it to RhoA signaling and showing both Rho-dependent and Rho-independent activities.

   Evidence Reciprocal overexpression/siRNA in human keratinocytes with actin/keratin imaging, GST-rhotekin Rho activity pulldown, clonal growth, and differentiation marker assays

   PMID:18840647

   Open questions at the time

   • Mechanism connecting kazrin to RhoA not defined
   • Identity of the Rho-independent pathway unknown
4. 2009 Medium

   Proposed an apoptosis-modulating role for the kazrin F isoform through interaction with ARC and Bax, expanding kazrin function beyond junctions.

   Evidence Co-IP, colocalization, siRNA knockdown with MTT and TUNEL assays

   PMID:19727525

   Open questions at the time

   • Single Co-IP without reciprocal validation or mutagenesis
   • No reconstitution of the apoptotic mechanism
   • Binding interface unmapped
5. 2010 High

   Identified the direct binding partners (ARVCF-catenin, β2-spectrin, p190B RhoGAP, δ-catenin/p0071) that mechanistically tie kazrin to cadherin function and RhoA regulation, with in vivo epistasis showing kazrin loss drives RhoA activation and cell shedding.

   Evidence Co-IP/GST pulldown, ternary complex resolution, and morpholino knockdown with ARVCF/p190B rescue in Xenopus embryos

   PMID:21062899

   Open questions at the time

   • Selectivity basis for p120-subfamily binding not resolved
   • How the kazrin–ARVCF–spectrin complex couples to actin/RhoA mechanistically unclear
6. 2011 Medium

   Extended the kazrin–ARVCF/δ-catenin axis to an organismal developmental requirement, showing kazrin is needed for neural crest and craniofacial development.

   Evidence Morpholino knockdown with ARVCF rescue, neural crest marker and cartilage histology in Xenopus

   PMID:22028074

   Open questions at the time

   • Limited new molecular mechanism beyond previously established partners
   • Cell-autonomy of neural crest defect not dissected
7. 2012 Medium

   Localized the cell-shape regulatory function to the N-terminal coiled-coil domain and showed exons 5–15 are dispensable for epidermal morphogenesis in vivo, refining the structure-function map.

   Evidence Gene-trap mouse expressing exon 1–4–β-gal fusion plus truncated-protein transfection and junctional immunofluorescence

   PMID:22513779

   Open questions at the time

   • Why full-length isoform functions are dispensable for skin not explained
   • No defect baseline complicates interpretation of redundancy
8. 2021 Low

   Placed KAZN downstream of a LINC00284/FUS axis as a stability-regulated, pro-tumorigenic transcript in oral squamous cell carcinoma.

   Evidence RNA immunoprecipitation, mRNA stability assay, and rescue experiments in OSCC cell lines

   PMID:33618612

   Open questions at the time

   • Single RIP and rescue, not independently confirmed
   • Mechanism by which KAZN promotes malignancy at the protein level untested
9. 2023 High

   Defined a mechanistically distinct role for the kazrin C isoform as a bona fide dynein/dynactin adaptor coupling early endosomes to retrograde transport.

   Evidence CRISPR knockout MEFs, direct pulldown of dynactin and dynein LIC1, endosome motility tracking, cargo internalization assays, and domain mapping

   PMID:37096882

   Open questions at the time

   • Relationship between the trafficking role and junctional/cytoskeletal roles unresolved
   • Cargo-selection logic of the C-terminal IDR not fully defined

• How kazrin's separable activities—desmosomal/junctional adaptor, RhoA-coupled cytoskeletal regulator, and dynein/dynactin endosomal adaptor—are coordinated across isoforms and tissues remains unresolved.
• No unified model linking isoform identity to function
• No structural model of kazrin complexes
• Physiological role of the apoptotic and cancer functions not integrated